Researcher
Herman Goossens
- Keywords:Medicine
- Disciplines:Evolutionary biology , General biology, Microbiology, Systems biology, Immunology, Laboratory medicine, Bacteriology, Infectious diseases, Social medical sciences
Affiliations
- Laboratory of Medical Microbiology (LMM) (Research group)
Responsible
From1 Jan 2019 → Today - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2003 → 31 Dec 2018
Projects
1 - 10 of 60 results
- Enhanced Networking on Antimicrobial Resistance Surveillance with Next Generation Sequencing (AmReSu).From1 Oct 2020 → TodayFunding: H2020 - Spreading excellence and widening participation
- The effectiveness of the preventive measures in primary care against SARS-CoV-2 using validated, non-invasive highly sensitive serological testingFrom1 Jun 2020 → TodayFunding: BOF - projects
- The impact of mixed or polymicrobial flora in the development of ventilator-associated pneumonia.From1 Oct 2019 → TodayFunding: BOF - doctoral mandates
- The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use (VALUE-Dx).From1 Apr 2019 → TodayFunding: H2020 - Health, demographic change and wellbeing, Foreign industrial entreprises
- Impact of duration of antibiotic therapy and of oral step-down to amoxicilin or co-amoxiclav on effectiveness, safety and selection of antimicrobial resistance in severe and very severe childhood community-acquired pneumonia (PediCAP Trial).From1 Apr 2019 → TodayFunding: Other European institutions (outside EU)
- Optimization of a microfluidic strip and device through design and engineering of the diagnosis rate of the minimum inhibitory concentrations (mi) of antibiotics (MIC-STRIP).From1 Feb 2019 → 31 Jul 2020Funding: IOF - Industrial Research Fund, Own budget, for example: patrimony, inscription fees, gifts
- European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan (ECRAID-Plan).From1 Jan 2019 → 31 Dec 2020Funding: H2020 - Health, demographic change and wellbeing
- European wide Innovative procurement of health innovation (EURIPHI).From1 Jan 2019 → 30 Jun 2020Funding: H2020 - Health, demographic change and wellbeing
- Selecting sites and laboratory support for the Merck study PN014.From3 Nov 2017 → 31 Dec 2019Funding: Foreign public sponsor
- Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections (Combacte - CDI).From1 Nov 2017 → 31 Oct 2020Funding: H2020 - Health, demographic change and wellbeing
Publications
1 - 10 of 338 results
- Adaptive platform trials: definition, design, conduct and reporting considerations The Adaptive Platform Trials Coalition(2019)
Authors: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, et al.
Pages: 797 - 807 - Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples(2019)
Authors: Jasmine Coppens, Liesbet Van Heirstraeten, Alexey Ruzin, Li Yu, Leen Timbermont, Christine Lammens, Veerle Matheeussen, Michael McCarthy, Philippe Jorens, Margareta Ieven, et al.
Number of pages: 7 - Comparison of the power of procalcitonin and C-reactive protein to discriminate between different aetiologies of fever in prolonged profound neutropenia(2019)
Authors: Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
Number of pages: 8 - Point prevalence survey of antimicrobial prescription and infection in pediatric and neonatal wards of two Iranian teaching hospitals(2019)
Authors: Jafar Soltani, Gholamreza Pouladfar, Ann Versporten, Mike Sharland, Herman Goossens, Zahra Jafarpour, Naseh Soleimanil
Pages: 25 - 32 - Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network(2019)
Authors: Tomislav Kostyanev, Tuba Vilken, Christine Lammens, Leen Timbermont, A. Van't Veen, Herman Goossens
Pages: 268 - 274 - Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe)(2019)
Authors: Yingfen Hsia, Brian R. Lee, Ann Versporten, Yonghong Yang, Julia Bielicki, Charlotte Jackson, Jason Newland, Herman Goossens, Nicola Magrini, Mike Sharland, et al.
Pages: E861 - E871 - Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium(2019)
Authors: Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, Stéphanie Blaizot, Jan Verhaegen, Pierre Van Damme, Surbhi Malhotra, Heidi Theeten, Barbara De Wilde, Marc De Meulemeester, et al.
Pages: 1080 - 1086 - Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training(2019)
Authors: Paul Little, Beth Stuart, Nick Francis, Sibyl Anthierens, Samuel Coenen, Herman Goossens, et al.
Pages: 125 - 132 - Development of a prediction tool for patients presenting with acute cough in primary care(2018)
Authors: Robin Bruyndonckx, Niel Hens, Theo J. M. Verheij, Marc Aerts, Margareta Ieven, Christopher C. Butler, Paul Little, Herman Goossens, Samuel Coenen
Pages: E342 - E350 - Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe(2018)
Authors: Raymond Oppong, Richard D. Smith, Paul Little, Theo Verheij, Christopher C. Butler, Herman Goossens, Samuel Coenen, Sue Jowett, Tracy E. Roberts, Felix Achana, et al.
Pages: 3189 - 3198